These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

959 related articles for article (PubMed ID: 28660349)

  • 1. Tumor-Associated Macrophages as Target for Antitumor Therapy.
    Sawa-Wejksza K; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):97-111. PubMed ID: 28660349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophages: implications in cancer immunotherapy.
    Petty AJ; Yang Y
    Immunotherapy; 2017 Mar; 9(3):289-302. PubMed ID: 28231720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma.
    Degroote H; Van Dierendonck A; Geerts A; Van Vlierberghe H; Devisscher L
    J Immunol Res; 2018; 2018():7819520. PubMed ID: 30410942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of DC-SIGN
    Hu B; Wang Z; Zeng H; Qi Y; Chen Y; Wang T; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
    Cancer Res; 2020 Apr; 80(8):1707-1719. PubMed ID: 32060149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumor associated macrophages (TAMs) via nanocarriers.
    Singh Y; Pawar VK; Meher JG; Raval K; Kumar A; Shrivastava R; Bhadauria S; Chourasia MK
    J Control Release; 2017 May; 254():92-106. PubMed ID: 28377038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.
    Jia XH; Feng GW; Wang ZL; Du Y; Shen C; Hui H; Peng D; Li ZJ; Kong DL; Tian J
    Oncotarget; 2016 Apr; 7(15):20934-44. PubMed ID: 26988913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic studies of tumor-associated macrophage immunotherapy.
    Cao J; Liu C
    Front Immunol; 2024; 15():1476565. PubMed ID: 39403370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-promoting tumor-associated macrophages: new vistas and open questions.
    Mantovani A; Germano G; Marchesi F; Locatelli M; Biswas SK
    Eur J Immunol; 2011 Sep; 41(9):2522-5. PubMed ID: 21952810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in tumor-associated macrophage (TAM)-targeted therapeutics.
    Ngambenjawong C; Gustafson HH; Pun SH
    Adv Drug Deliv Rev; 2017 May; 114():206-221. PubMed ID: 28449873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.
    Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R
    Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
    Wang H; Yung MMH; Ngan HYS; Chan KKL; Chan DW
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
    Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
    J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting tumor-associated macrophages for cancer immunotherapy.
    Shu Y; Cheng P
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188434. PubMed ID: 32956767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy.
    Guo Q; Jin Z; Yuan Y; Liu R; Xu T; Wei H; Xu X; He S; Chen S; Shi Z; Hou W; Hua B
    J Immunol Res; 2016; 2016():9720912. PubMed ID: 27975071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering Macrophages for Cancer Immunotherapy and Drug Delivery.
    Xia Y; Rao L; Yao H; Wang Z; Ning P; Chen X
    Adv Mater; 2020 Oct; 32(40):e2002054. PubMed ID: 32856350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
    Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
    Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies.
    Kumari N; Choi SH
    J Exp Clin Cancer Res; 2022 Feb; 41(1):68. PubMed ID: 35183252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses.
    Anfray C; Ummarino A; Andón FT; Allavena P
    Cells; 2019 Dec; 9(1):. PubMed ID: 31878087
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of tumor-associated macrophages in tumor immune evasion.
    Huang R; Kang T; Chen S
    J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Evasion in Cancer Is Regulated by Tumor-Asociated Macrophages (TAMs): Targeting TAMs.
    Jung M; Bonavida B
    Crit Rev Oncog; 2024; 29(4):1-17. PubMed ID: 38989734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.